National Guideline Clearinghouse | Mitotane for the management of adrenocortical carcinoma.

full-text ►

National Guideline Clearinghouse | Mitotane for the management of adrenocortical carcinoma.



CancerControl Alberta

Guideline Title

Mitotane for the management of adrenocortical carcinoma.

Bibliographic Source(s)

Alberta Provincial Endocrine Tumour Team. Mitotane for the management of adrenocortical carcinoma. Edmonton (Alberta): CancerControl Alberta; 2013 Nov. 9 p. (Clinical practice guideline; no. ENDO-005).  [24 references]

Guideline Status

This is the current release of the guideline.